There has been some encouraging news from the team behind the Oxford University coronavirus vaccine, as their phase two trials show it promotes a strong immune response in older people – the generation most at risk. (Subscribe:
They are now moving on to larger trials aimed at finding out whether the jab will stop people developing Covid in the first place.
———————–
Follow us on Instagram –
